Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: A retrospective study

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Kim, Mi Jung ^a   Oh, Do Youn ^a,b   Lee, Se Hoon ^a,b   Kim, Dong Wan ^a,b   Im, Seock Ah ^a,b   Kim, Tae You ^a,b   Heo, Dae ^a,b   Bang, Yung Jue ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CAPECITABINE; CISPLATIN; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; OXALIPLATIN; PLATINUM COMPLEX; UFT; 1 UFT PROTOCOL; 1-UFT PROTOCOL; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; OXONIC ACID; PYRIMIDINONE DERIVATIVE; S 1 (COMBINATION); TEGAFUR; URACIL;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GALLBLADDER CANCER; HUMAN; INOPERABLE CANCER; KOREA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OVERALL SURVIVAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VATER PAPILLA CARCINOMA; BILIARY TRACT TUMOR; COMPARATIVE STUDY; DRUG COMBINATION; METHODOLOGY; MIDDLE AGED; PALLIATIVE THERAPY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILIARY TRACT NEOPLASMS; CISPLATIN; DEOXYCYTIDINE; DRUG COMBINATIONS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; OXONIC ACID; PALLIATIVE CARE; PYRIMIDINONES; RETROSPECTIVE STUDIES; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 58149379868     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-374     Document Type: Article

References (36)

1. Jemal A Siegel R Ward E Murray T Xu J Thun MJ Cancer statistics, 2007 CA: A cancer journal for clinicians 2007, 57:43-66 17237035
2. Shin HR Jung KW Won YJ Park JG 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 Hospitals Cancer Res Treat 2004, 36:103-114
3. Leonard GD O'Reilly EM Biliary tract cancers: Current concepts and controversies Expert opinion on pharmacotherapy 2005, 6:211-223 10.1517/ 14656566.6.2.211 15757418
4. Vauthey JN Blumgart LH Recent advances in the management of cholangiocarcinomas Seminars in liver disease 1994, 14:109-114 10.1055/ s-2007-1007302 8047893
5. Glimelius B Hoffman K Sjoden PO Jacobsson G Sellstrom H Enander LK Linne T Svensson C Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer Ann Oncol 1996, 7:593-600 8879373
6. Falkson G MacIntyre JM Moertel CG Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer Cancer 1984, 54:965-969 10.1002/ 1097-0142(19840915)54:6<965::AID-CNCR2820540603>3.0.CO;2-X 6235908
7. Harvey JH Smith FP Schein PS 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract J Clin Oncol 1984, 2:1245-1248 6092556
8. Ducreux M Rougier P Fandi A Clavero-Fabri MC Villing AL Fassone F Fandi L Zarba J Armand JP Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin Ann Oncol 1998, 9:653-656 10.1023/A:1008241008379 9681080
9. Ducreux M van Cutsem E van Laethem JL Gress TM Jeziorski K Rougier P Wagener T Anak O Baron B Nordlinger B A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: Results of the 40955 EORTC trial Eur J Cancer 2005, 41:398-403 10.1016/ j.ejca.2004.10.026 15691639
10. Okusaka T Ishii H Funakoshi A Yamao K Ohkawa S Saito S Saito H Tsuyuguchi T Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer Cancer chemotherapy and pharmacology 2006, 57:647-653 10.1007/s00280-005-0095-3
11. Kiba T Nishimura T Matsumoto S Hatano E Mori A Yasumi S Doi R Ikai I Kitano T Nishimura T Yoshikawa K Ishiguro H Yanagihara K Doi E Teramukai S Fukushima M Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature Oncology 2006, 70:358-365 10.1159/000098109 17179730
12. Lee J Kim TY Lee MA Ahn MJ Kim HK Lim HY Lee NS Park BJ Kim JS Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas Cancer chemotherapy and pharmacology 2008, 61:47-52 10.1007/s00280-007-0444-5
13. Kim ST Park JO Lee J Lee KT Lee JK Choi SH Heo JS Park YS Kang WK Park K A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer Cancer 2006, 106:1339-1346 10.1002/cncr.21741 16475213
14. Thongprasert S Napapan S Charoentum C Moonprakan S Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma Ann Oncol 2005, 16:279-281 10.1093/annonc/mdi046 15668284
15. Knox JJ Hedley D Oza A Siu LL Pond GR Moore MJ Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: A review of the Princess Margaret Hospital experience Ann Oncol 2004, 15:770-774 10.1093/annonc/mdh172 15111345
16. Knox JJ Hedley D Oza A Feld R Siu LL Chen E Nematollahi M Pond GR Zhang J Moore MJ Combining gemcitabine and capecitabine in patients with advanced biliary cancer: A phase II trial J Clin Oncol 2005, 23:2332-2338 10.1200/JCO.2005.51.008 15800324
17. Androulakis N Aravantinos G Syrigos K Polyzos A Ziras N Tselepatiotis E Samonis G Kentepozidis N Giassas S Vamvakas L Georgoulias V Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: A multicenter phase II study Oncology 2006, 70:280-284 10.1159/000096249 17047399
18. Hong YS Lee J Lee SC Hwang IG Choi SH Heo JS Park JO Park YS Lim HY Kang WK Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer Cancer chemotherapy and pharmacology 2007, 60:321-328 10.1007/s00280-006-0380-9
19. Kim YJ Im SA Kim HG Oh SY Lee KW Choi IS Oh DY Lee SH Kim JH Kim DW Kim TY Kim SW Heo DS Yoon YB Bang YJ A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer Ann Oncol 2008, 19:99-103 10.1093/annonc/mdm439 17846018
20. Ueno H Okusaka T Ikeda M Takezako Y Morizane C Phase II study of S-1 in patients with advanced biliary tract cancer British journal of cancer 2004, 91:1769-1774 10.1038/sj.bjc.6602208 15505626
21. Park SH Park YH Lee JN Bang SM Cho EK Shin DB Lee JH Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma Cancer 2006, 106:361-365 10.1002/cncr.21621 16342166
22. Therasse P Arbuck SG Eisenhauer EA Wanders J Kaplan RS Rubinstein L Verweij J van Glabbeke M van Oosterom AT Christian MC Gwyther SG New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 2000, 92:205-216 10.1093/jnci/92.3.205 10655437
23. Anderson JR Bernstein L Pike MC Approximate confidence intervals for probabilities of survival and quantiles in life-table analysis Biometrics 1982, 38:407-416 10.2307/2530454 7115871
24. Furuse J Okusaka T Funakoshi A Yamao K Nagase M Ishii H Nakachi K Ueno H Ikeda M Morizane C Horikawa Y Mizuno N Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer Japanese journal of clinical oncology 2006, 36:552-556 10.1093/jjco/hyl075 16887837
25. Pasetto LM D'Andrea MR Falci C Monfardini S Gemcitabine in advanced biliary tract cancers Critical reviews in oncology/hematology 2007, 61:230-242 10.1016/j.critrevonc.2006.04.006 17157524
26. Scheithauer W Review of gemcitabine in biliary tract carcinoma Seminars in oncology 2002, 29:40-45 12577232
27. Tsavaris N Kosmas C Gouveris P Gennatas K Polyzos A Mouratidou D Tsipras H Margaris H Papastratis G Tzima E Papadoniou N Karatzas G Papalambros E Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer Invest New Drugs 2004, 22:193-198 10.1023/ B:DRUG.0000011797.09549.53 14739669
28. Giuliani F Gebbia V Maiello E Borsellino N Bajardi E Colucci G Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: A multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM) Ann Oncol 2006, 17(Suppl 7):vIi73-77 10.1093/annonc/mdl956 16760299
29. Manzione L Romano R Germano D Chemotherapy with gemcitabine and oxaliplatin in patients with advanced biliary tract cancer: A single-institution experience Oncology 2007, 73:311-315 10.1159/ 000134239 18493158
30. Yonemoto N Furuse J Okusaka T Yamao K Funakoshi A Ohkawa S Boku N Tanaka K Nagase M Saisho H Sato T A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer Japanese journal of clinical oncology 2007, 37:843-851 10.1093/jjco/ hym116 17942578
31. Okada S Ishii H Nose H Yoshimori M Okusaka T Aoki K Iwasaki M Furuse J Yoshino M A phase II study of cisplatin in patients with biliary tract carcinoma Oncology 1994, 51:515-517 7970496
32. Bergman AM Ruiz van Haperen VW Veerman G Kuiper CM Peters GJ Synergistic interaction between cisplatin and gemcitabine in vitro Clin Cancer Res 1996, 2:521-530 9816199
33. Shirasaka T Shimamoto Y Ohshimo H Saito H Fukushima M Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo Cancer chemotherapy and pharmacology 1993, 32:167-172 10.1007/BF00685830
34. Eckel F Schmid RM Chemotherapy in advanced biliary tract carcinoma: A pooled analysis of clinical trials British journal of cancer 2007, 96:896-902 10.1038/sj.bjc.6603648 17325704
35. Philip PA Mahoney MR Allmer C Thomas J Pitot HC Kim G Donehower RC Fitch T Picus J Erlichman C Phase II study of erlotinib in patients with advanced biliary cancer J Clin Oncol 2006, 24:3069-3074 10.1200/ JCO.2005.05.3579 16809731
36. Paule B Herelle MO Rage E Ducreux M Adam R Guettier C Bralet MP Cetuximab plus gemcitabine-oxaliplatin (GEMOX) in patients with refractory advanced intrahepatic cholangiocarcinomas Oncology 2007, 72:105-110 10.1159/000111117 18025804